Search results
Federal Circuit Overrules Rosen-Durling Test for Design Patent Obviousness as “Improperly Rigid” |...
JD Supra· 5 days agoStoll, J. The Court vacated a final written decision of the Patent Trial and Appeal Board finding a design patent nonobvious and remanded. Appellants filed a petition to institute an inter partes ...
Netgear director Butterfass Sarah sells over $75k in company stock By Investing.com
Investing.com· 5 days agoThe sale took place on June 4, 2024, and was conducted under a Rule 10b5-1 trading plan, which...
Judge denies United Therapeutics' attempt to block Liquidia from expanding PAH drug - Triangle...
The Business Journals· 6 days agoUnited Therapeutics (Nasdaq: UTHR) last year filed a patent infringement lawsuit against Liquidia...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 5 days agoIntellectual Property Attorneys at Dallas' Caldwell Cassady & Curry Earn IAM Patent 1000 Honors PR Newswire DALLAS, June 5, 2024 DALLAS, June 5, 2024 /PRNewswire/ -- The Dallas intellectual property and business litigation firm Caldwell Cassady
Expert Perspectives on Biggest Court Cases
Law.com· 6 days agoLast week Jason Sheasby and Lisa Glasser were part of an Irell & Manella team that nabbed runners-up honors for Litigator of the Week after bringing home...
Inari's Expanding Product Portfolio Offsets Competition - Boston Scientific (NYSE:BSX), Align Tech...
Benzinga· 6 days agoInari Medical NARI continues to ride on the success of its ClotTriever and FlowTriever products...
Qiagen Shutters NeuMoDx Business, Reaffirms Q2 Outlook
GenomeWeb News· 3 days agoCiting changing customer needs for integrated PCR-based clinical molecular testing systems, Qiagen announced on Thursday that it will discontinue its NeuMoDx business. "This decision underscores ...
Inari's (NARI) Expanding Product Portfolio Offsets Competition
Zacks· 7 days agoFree Report) continues to ride on the success of its ClotTriever and FlowTriever products available for treating venous thromboembolism (VTE). The adoption of these products is rising on the ...
